| Presented by: | The Johns Hopkins University School of Medicine |
| Lecturer | Several lecturers |
| Approximate duration: | 2 hrs. |
| Summary points: | This text-based presentation provides an overview of new protocols using immunosuppressive drugs to improve long-term graft survival in heart transplant patients, uses of new immunosuppressive agents and regimens to reduce toxicity in the prevention and treatment of acute allograft rejection, ways to minimise immunosuppressive complications leading to increased morbidity and mortality, and newer prophylactic strategies to improve outcomes of at-risk patients. |
| Accreditation: | The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s).
Expiration date: May 15, 2010. |
| Other: | Text-only CME. |
Heart Transplantation Clinical and Scientific Updates: Improving Long-term Outcomes
